Longitudinal changes in body composition during palliative systemic chemotherapy and survival outcomes in metastatic colorectal cancer

doi:10.4251/wjgo.v17.i5.103479

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (669)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-3) series.

Item

Count

PDF

HTML

330

Figures (1-5)

110

Tables (1-3)

117

Sum=578

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=64

May 15, 2025 (publication date) through Jun 11, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Oncol. May 15, 2025; 17(5): 103479
Published online May 15, 2025. doi: 10.4251/wjgo.v17.i5.103479

Full Size Figure Download Figure

Figure 2 Class changes in body composition during treatment. Percentage changes in the prevalence of abnormal body composition from baseline to after the last systemic chemotherapy were shown. S: Sarcopenia; ScO: Subcutaneous obesity; M: Myosteatosis; mo: Months; VO: Visceral obesity.

Citation: Jeong H, Ko Y, Kim KW, Lee JS, Seo S, Kim SY, Hong YS, Kim JE, Kim TW. Longitudinal changes in body composition during palliative systemic chemotherapy and survival outcomes in metastatic colorectal cancer. World J Gastrointest Oncol 2025; 17(5): 103479
URL: https://www.wjgnet.com/1948-5204/full/v17/i5/103479.htm
DOI: https://dx.doi.org/10.4251/wjgo.v17.i5.103479